← back to dashboard

TNON

Tenon Medical, Inc.
Composite
0.05
EDGAR
0.05
Filings (90d)
9
Peak
0.09
Last Signal
2026-10-22T17:02

All Filings

Filed Form Items Signal Score Summary Link
2026-10-22 17:02 8-K ["1.01", "9.01"] other 0.05 Financing waiver and warrant issuance; no M&A signals present. SEC · detail
2026-09-16 17:23 8-K ["1.01", "3.02", "8.01", "9.01"] other 0.05 Warrant inducement transaction and equity capital raise; no M&A signals present. SEC · detail
2026-09-09 08:45 8-K ["8.01", "9.01"] other 0.05 Routine debt repayment announcement with no M&A signals or strategic transaction indicators. SEC · detail
2026-08-31 15:40 8-K ["1.01", "3.02", "8.01"] other 0.05 Private placement financing with warrants; no M&A signals detected. SEC · detail
2026-08-26 15:30 8-K ["1.01", "3.02", "8.01", "9.01"] other 0.05 Private convertible note offering; financing activity unrelated to M&A, merger, or acquisition. SEC · detail
2026-08-24 13:23 8-K ["8.01", "9.01"] other 0.05 Nasdaq compliance notice; no M&A signal. Company regained minimum bid price requirement. SEC · detail
2026-08-13 16:25 8-K ["2.02", "9.01"] other 0.05 Routine Q2 2026 earnings announcement with conference call; no M&A signals. SEC · detail
2026-08-10 17:26 8-K ["3.03", "5.03", "7.01", "9.01"] other 0.05 Reverse stock split (1-for-35) announcement; no M&A signal detected. SEC · detail
2026-07-24 16:45 8-K ["5.07"] other 0.05 Routine annual stockholder meeting with director elections and voting results; no M&A signal. SEC · detail
2026-07-20 08:15 8-K ["8.01", "9.01"] other 0.05 8-K discloses Nasdaq compliance regained after capital raise; no M&A signals present. SEC · detail
2026-07-10 17:19 8-K ["8.01"] other 0.05 8-K Item 8.01 disclosure of Nasdaq compliance efforts via equity offering; no M&A signal. SEC · detail
2026-07-02 16:05 8-K ["1.01"] other 0.05 Securities offering (capital raise) unrelated to M&A, merger, or acquisition activity. SEC · detail
2026-06-12 17:20 8-K ["1.01", "5.02", "9.01"] other 0.15 Routine executive compensation increases and consulting agreement renewal; no M&A indicators present. SEC · detail
2026-06-11 16:05 8-K ["5.03", "9.01"] other 0.15 Bylaw amendments lowering quorum and voting thresholds; routine governance change with no M&A implications. SEC · detail
2026-05-22 17:15 8-K ["3.01"] other 0.15 Nasdaq delisting notice due to insufficient stockholders' equity; no M&A signal. SEC · detail
2026-05-12 16:16 8-K ["2.02", "9.01"] other 0.05 Routine Q1 2026 earnings announcement with conference call; no M&A signals. SEC · detail